Literature DB >> 8564967

Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats.

C V Rao1, B Simi, T T Wynn, K Garr, B S Reddy.   

Abstract

Epidemiological and laboratory animal model studies suggest that the effect of dietary fat in colon carcinogenesis depends not only on the amount but on its fatty acid composition. Animal model studies demonstrated that high dietary corn oil or safflower oil rich in omega-6 fatty acids increased the colon tumor promotion, whereas diets containing fish oil high in omega-3 fatty acids had no such enhancing effect. One of the mechanisms by which high dietary fat enhances colon carcinogenesis may be through the modulation of colonic mucosal phospholipase A2 (PLA2) and phosphatidylinositol-specific phospholipase C (PI-PLC), which are dominant pathways for arachidonic acid release and formation of eicosanoids. PI-PLC is also responsible for diacylglycerol formation and protein kinase C-dependent signal transduction and cell proliferation. In the present study, we investigated the modulating effect of high fat diets rich in omega-3 and omega-6 fatty acids on colonic mucosal PLA2, PI-PLC activities, and eicosanoid (prostaglandins and thromboxane B2) formation from arachidonic acid via cyclooxygenase (COX) during different stages of azoxymethane (AOM)-induced colon carcinogenesis in male F344 rats. At 5 weeks of age, groups of animals were fed the low-fat diet containing 5% corn oil. Beginning at 7 weeks of age, all animals except those intended for vehicle treatment received AOM s.c. once weekly for 2 weeks at a dose rate of 15 mg/kg body weight. Vehicle-treated groups received an equal volume of normal saline. One day after the second AOM or vehicle treatment, groups of animals were transferred to experimental diets containing 23.5% corn oil and 20.5% fish oil + 3% corn oil, whereas one group continued on the low-fat diet containing 5% corn oil. Groups of animals were then sacrificed at weeks 1, 12, and 36 after the second AOM-or saline-treatment. Colonic mucosa harvested at weeks 1, 12, and 36 and colonic tumors obtained at week 36 were analyzed for PLA2, PI-PLC, and eicosanoid formation from arachidonic acid by the action of COX. The results demonstrate that colon carcinogen treatment increases the activities of colonic mucosal PLA2 and PI-PLC and the formation of prostaglandins and thromboxane A2 from arachidonic acid through COX throughout the study period compared to saline-treated animals fed similar diets. The activities of PLA2, PI-PLC, and COX were significantly higher in colon tumors compared to colonic mucosa. These results also demonstrate that a high-fat diet containing corn oil increases colonic mucosal and tumor PLA2 and PI-PLC and the formation of prostaglandins and thromboxane B2 by the action of COX as compared to low dietary corn oil or a diet high in fish oil. The results of our study offer one of the mechanisms by which the amount and types of dietary fat modulate colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564967

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon.

Authors:  Zora Djuric
Journal:  Nutr Rev       Date:  2011-12       Impact factor: 7.110

2.  Interaction of fatty acid genotype and diet on changes in colonic fatty acids in a Mediterranean diet intervention study.

Authors:  Shannon R Porenta; Yi-An Ko; Stephen B Gruber; Bhramar Mukherjee; Ana Baylin; Jianwei Ren; Zora Djuric
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-10

3.  Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis.

Authors:  R Bartolí; F Fernández-Bañares; E Navarro; E Castellà; J Mañé; M Alvarez; C Pastor; E Cabré; M A Gassull
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

4.  Microarray analysis of anti-cancer effects of docosahexaenoic acid on human colon cancer model in nude mice.

Authors:  Shitao Zou; Xingjun Meng; You Meng; Jin Liu; Biao Liu; Shuyu Zhang; Weiqun Ding; Jinchang Wu; Jundong Zhou
Journal:  Int J Clin Exp Med       Date:  2015-04-15

5.  Advanced glycation end products (AGE) induce the receptor for AGE in the colonic mucosa of azoxymethane-injected Fischer 344 rats fed with a high-linoleic acid and high-glucose diet.

Authors:  Takasumi Shimomoto; Yi Luo; Hitoshi Ohmori; Yoshitomo Chihara; Kiyomu Fujii; Tomonori Sasahira; Ayumi Denda; Hiroki Kuniyasu
Journal:  J Gastroenterol       Date:  2012-03-31       Impact factor: 7.527

6.  Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells.

Authors:  Ravinder Tammali; Kota V Ramana; Satish K Srivastava
Journal:  Cancer Lett       Date:  2007-02-14       Impact factor: 8.679

7.  Dose-dependent inhibition of cell proliferation induced by lipid peroxidation products in rat hepatoma cells after enrichment with arachidonic acid.

Authors:  G Muzio; R A Salvo; A Trombetta; R Autelli; M Maggiora; M Terreno; M U Dianzani; R A Canuto
Journal:  Lipids       Date:  1999-07       Impact factor: 1.880

8.  Classification of diet-modulated gene signatures at the colon cancer initiation and progression stages.

Authors:  Priyanka Kachroo; Ivan Ivanov; Laurie A Davidson; Bhanu P Chowdhary; Joanne R Lupton; Robert S Chapkin
Journal:  Dig Dis Sci       Date:  2011-03-16       Impact factor: 3.199

9.  Types and amount of dietary fat and colon cancer risk: Prevention by omega-3 fatty acid-rich diets.

Authors:  Bandaru S Reddy
Journal:  Environ Health Prev Med       Date:  2002-07       Impact factor: 3.674

Review 10.  Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system.

Authors:  Denis E Corpet; Fabrice Pierre
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.